Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Trastornos del Movimiento

90 ARTÍCULOS , VIENDO DEL 31 AL 45

Medical comorbidity of sleep disorders

Dikeos D, Georgantopoulos G.

Curr Opin Psychiatry. 2011 Jul;24(4):346-54. doi: 10.1097/YCO.0b013e3283473375.

[Restless legs syndrome and diabetes mellitus: an accidental association?]

Greco D.

Recenti Prog Med. 2011 May;102(5):212-6. doi: 10.1701/659.7671.

Randomized polysomnography study of gabapentin enacarbil in subjects with restless legs syndrome

Winkelman JW, Bogan RK, Schmidt MH, Hudson JD, DeRossett SE, Hill-Zabala CE.

Mov Disord. 2011 Sep;26(11):2065-72. doi: 10.1002/mds.23771. Epub 2011 May 24.

Migraine and restless legs syndrome: is there an association?

Cannon PR, Larner AJ.

J Headache Pain. 2011 Aug;12(4):405-9. doi: 10.1007/s10194-011-0357-x. Epub 2011 Jun 10.

A randomized, double-blind, placebo-controlled study to assess the efficacy and tolerability of gabapentin enacarbil in subjects with restless legs syndrome

Lee DO, Ziman RB, Perkins AT, Poceta JS, Walters AS, Barrett RW; XP053 Study Group.

J Clin Sleep Med. 2011 Jun 15;7(3):282-92. doi: 10.5664/JCSM.1074.

Long-term safety and efficacy of rotigotine transdermal patch for moderate-to-severe idiopathic restless legs syndrome: a 5-year open-label extension study

Oertel W, Trenkwalder C, Beneš H, Ferini-Strambi L, Högl B, Poewe W, Stiasny-Kolster K, Fichtner A, Schollmayer E, Kohnen R, García-Borreguero D; SP710 study group.

Lancet Neurol. 2011 Aug;10(8):710-20. doi: 10.1016/S1474-4422(11)70127-2. Epub 2011 Jun 24.

Possible sites of therapeutic action in restless legs syndrome: focus on dopamine and α2δ ligands

Thorpe AJ, Clair A, Hochman S, Clemens S.

Eur Neurol. 2011;66(1):18-29. doi: 10.1159/000328431. Epub 2011 Jun 28.

Restless legs syndrome-associated MEIS1 risk variant influences iron homeostasis

Catoire H, Dion PA, Xiong L, Amari M, Gaudet R, Girard SL, Noreau A, Gaspar C, Turecki G, Montplaisir JY, Parker JA, Rouleau GA.

Ann Neurol. 2011 Jul;70(1):170-5. doi: 10.1002/ana.22435. Epub 2011 Jun 27.

Preferential D2 or preferential D3 dopamine agonists in restless legs syndrome

Manconi M, Ferri R, Zucconi M, Clemens S, Giarolli L, Bottasini V, Ferini-Strambi L.

Neurology. 2011 Jul 12;77(2):110-7. doi: 10.1212/WNL.0b013e3182242d91. Epub 2011 Jun 29.

[Restless legs syndrome and nocturnal leg pain : Differential diagnosis and treatment]

Hornyak M, Stiasny-Kolster K, Evers S, Happe S.

Schmerz. 2011 Sep;25(5):544-51. doi: 10.1007/s00482-011-1074-8.

Development and validation of a subjective post sleep diary (SPSD) to assess sleep status in subjects with restless legs syndrome

Calloway M, Bharmal M, Hill-Zabala C, Allen R.

Sleep Med. 2011 Aug;12(7):704-10. doi: 10.1016/j.sleep.2010.09.020. Epub 2011 Jul 5.

Bupropion and restless legs syndrome: a randomized controlled trial

Bayard M, Bailey B, Acharya D, Ambreen F, Duggal S, Kaur T, Rahman ZU, Roller K, Tudiver F.

J Am Board Fam Med. 2011 Jul-Aug;24(4):422-8. doi: 10.3122/jabfm.2011.04.100173.

Pilot trial of onabotulinumtoxina (Botox) in moderate to severe restless legs syndrome

Agarwal P, Sia C, Vaish N, Roy-Faderman I.

Int J Neurosci. 2011 Nov;121(11):622-5. doi: 10.3109/00207454.2011.602774. Epub 2011 Aug 10.

Prevalence of restless legs syndrome in North American and Western European populations: a systematic review

Innes KE, Selfe TK, Agarwal P.

Sleep Med. 2011 Aug;12(7):623-34. doi: 10.1016/j.sleep.2010.12.018. Epub 2011 Jul 12.

Restless legs syndrome probably due to clozapine

Chathanchirayil SJ.

Aust N Z J Psychiatry. 2011 Nov;45(11):1005-6. doi: 10.3109/00048674.2011.594949. Epub 2011 Jul 21.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias